Allowing people to mix COVID-19 vaccines could cut into Pfizer and Moderna's revenue next year

Retrieved on: 2021-10-06 17:07:36

Tags for this article:

Click the tags to see associated articles and topics

Allowing people to mix COVID-19 vaccines could cut into Pfizer and Moderna's revenue next year. View article details on hiswai:

Excerpt

AstraZeneca, J&J, Moderna, and Pfizer are expected to bring in $46 billion in revenue for their COVID-19 shots in 2022 ...

Article found on: www.marketwatch.com